Table 1 Estimated number of directly averted events (hospitalizations, ICU admissions and deaths) by age, in the French population aged 50 years and above, from week 53–2020 to week 9–2022
Event | Age group (years) | Number of events | Rate per 100,000 | Percentage averted by vaccination (95% CI) | ||
|---|---|---|---|---|---|---|
Observed | Averted by vaccination (95% CI) | Observed | Expected without vaccination (95% CI) | |||
Hospitalizations | 50–59 | 43,757 | 71,526 (37,934–85,122) | 492.2 | 1296.7 (918.8–1449.6) | 62.0 (46.4–66.0) |
60–69 | 59,246 | 107,642 (57,120–126,159) | 734.5 | 2069.0 (1442.7–2298.6) | 64.5 (49.1–68.0) | |
70–79 | 68,041 | 134,862 (71,915–155,691) | 1092.4 | 3257.5 (2246.9–3591.9) | 66.5 (51.4–69.6) | |
80 + | 108,399 | 166,120 (93,103–215,544) | 2625.4 | 6648.8 (4880.3–7845.8) | 60.5 (46.2–66.5) | |
All (50 +) | 279,443 | 480,150 (260,072–582,516) | 1023.1 | 2780.9 (1975.2–3155.7) | 63.2 (48.2–67.6) | |
ICU admissions | 50–59 | 13,651 | 28,074 (9636–33,776) | 153.5 | 469.3 (261.9–533.4) | 67.3 (41.4–71.2) |
60–69 | 20,175 | 44,790 (16,700–52,992) | 250.1 | 805.4 (457.2–907.1) | 68.9 (45.3–72.4) | |
70–79 | 18,683 | 44,007 (17,595–51,144) | 299.9 | 1006.5 (582.4–1121.0) | 70.2 (48.5–73.2) | |
80 + | 7677 | 15,285 (6478–19,855) | 185.9 | 556.1 (342.8–666.8) | 66.6 (45.8–72.1) | |
All (50 +) | 60,186 | 132,156 (50,409–157,767) | 220.3 | 704.2 (404.9–797.9) | 68.7 (45.6–72.4) | |
Deaths | 50–59 | 2839 | 5852 (2285–6853) | 31,9 | 97.8 (57.6–109.0) | 67.3 (44.6–70.7) |
60–69 | 8170 | 16,837 (6568–19,473) | 101,3 | 310.0 (182.7–342.7) | 67.3 (44.6–70.4) | |
70–79 | 15,593 | 32,136 (13,651–36,758) | 250,3 | 766.3 (469.5–840.5) | 67.3 (46.7–70.2) | |
80 + | 48,088 | 70,551 (31,288–88,953) | 1164.7 | 2873.4 (1922.5–3319.1) | 59.5 (39.4–64.9) | |
All (50 +) | 74,690 | 125,376 (53,792–152,037) | 273.4 | 732.5 (470.4–830.1) | 62.7 (41.9–67.1) | |